ATE229524T1 - Distamycin a analoga als antitumor- oder antivirale wirkstoffe - Google Patents

Distamycin a analoga als antitumor- oder antivirale wirkstoffe

Info

Publication number
ATE229524T1
ATE229524T1 AT95926927T AT95926927T ATE229524T1 AT E229524 T1 ATE229524 T1 AT E229524T1 AT 95926927 T AT95926927 T AT 95926927T AT 95926927 T AT95926927 T AT 95926927T AT E229524 T1 ATE229524 T1 AT E229524T1
Authority
AT
Austria
Prior art keywords
antitumor
analogas
distamycin
active ingredients
pct
Prior art date
Application number
AT95926927T
Other languages
English (en)
Inventor
Italo Beria
Enrico Pesenti
Laura Capolongo
Nicola Mongelli
Piergiovanni Baraldi
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of ATE229524T1 publication Critical patent/ATE229524T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Gas Burners (AREA)
  • Pre-Mixing And Non-Premixing Gas Burner (AREA)
  • Nozzles For Spraying Of Liquid Fuel (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95926927T 1994-08-08 1995-07-18 Distamycin a analoga als antitumor- oder antivirale wirkstoffe ATE229524T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416005A GB9416005D0 (en) 1994-08-08 1994-08-08 Peptidic compounds analogous to distamycin a and process for their preparation
PCT/EP1995/002814 WO1996005196A1 (en) 1994-08-08 1995-07-18 Distamycin a analogues as antitumour or antiviral agents

Publications (1)

Publication Number Publication Date
ATE229524T1 true ATE229524T1 (de) 2002-12-15

Family

ID=10759569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95926927T ATE229524T1 (de) 1994-08-08 1995-07-18 Distamycin a analoga als antitumor- oder antivirale wirkstoffe

Country Status (19)

Country Link
US (1) US5753629A (de)
EP (1) EP0722446B1 (de)
JP (1) JPH09504039A (de)
KR (1) KR960704884A (de)
CN (1) CN1131946A (de)
AT (1) ATE229524T1 (de)
AU (1) AU689623B2 (de)
CA (1) CA2172629A1 (de)
DE (1) DE69529143T2 (de)
ES (1) ES2188666T3 (de)
FI (1) FI961506A7 (de)
GB (1) GB9416005D0 (de)
HU (1) HUT76267A (de)
IL (1) IL114794A0 (de)
NO (1) NO961377L (de)
NZ (1) NZ290404A (de)
PL (1) PL313821A1 (de)
WO (1) WO1996005196A1 (de)
ZA (1) ZA956590B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515897A (ja) 1996-02-26 2002-05-28 カリフォルニア・インスティチュート・オブ・テクノロジー 特異的ポリアミドdna−結合リガンドの設計、合成、および使用
EP0968186A1 (de) * 1996-02-26 2000-01-05 California Institute Of Technology Polyamide zum binden an den kleinen graben von doppelsträngiger dna
US6555692B1 (en) 1996-02-26 2003-04-29 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
CN1260006A (zh) * 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
WO1998045284A1 (en) 1996-02-26 1998-10-15 California Institute Of Technology Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
US6506906B1 (en) 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
GB9610079D0 (en) * 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9806692D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9806689D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
US6384005B1 (en) * 1998-04-27 2002-05-07 Procter & Gamble Company Garment conditioning composition
GB9812211D0 (en) 1998-06-05 1998-08-05 Pharmacia & Upjohn Spa Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
CA2403537A1 (en) * 2000-03-16 2001-10-11 Genesoft, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
US7078536B2 (en) * 2001-03-14 2006-07-18 Genesoft Pharmaceuticals, Inc. Charged compounds comprising a nucleic acid binding moiety and uses therefor
GB0011059D0 (en) * 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0029004D0 (en) 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002088119A1 (en) * 2001-04-26 2002-11-07 Genesoft Pharmaceuticals, Inc Halogen-substituted thienyl compounds
EP1470119A4 (de) * 2001-06-13 2005-10-19 Genesoft Pharmaceuticals Inc Benzothiophenverbindungen mit antiinfektiver wirkung
US20030236198A1 (en) * 2001-06-13 2003-12-25 Genesoft, Inc. Antipathogenic benzamide compounds
ITTO20010633A1 (it) 2001-07-02 2003-01-02 Univ Ferrara Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale distamicina a.
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
ATE425753T1 (de) 2002-08-02 2009-04-15 Genesoft Pharmaceuticals Inc Biaryl-verbindungen mit antiinfektiver wirkung
EP1562931A2 (de) * 2002-10-25 2005-08-17 Genesoft Pharmaceuticals, Inc. Biarylverbindungen mitantiinfektionswirkung
JP2006509027A (ja) * 2002-12-10 2006-03-16 オーシェント ファーマシューティカルズ コーポレーション (ピロールカルボキサミド)−(ベンズアミド)−(イミダゾールカルボキサミド)モチーフを有する抗菌化合物
JP2006525361A (ja) * 2003-05-02 2006-11-09 エラン ファーマシューティカルズ,インコーポレイテッド ブラジキニンb1受容体アンタゴニストとしての選択された置換ピラゾール誘導体および関連化合物
EP1633349A1 (de) * 2003-05-02 2006-03-15 Elan Pharmaceuticals, Inc. 4-bromo-5- (2-chlorobenzoylamino)-1h-pyrazol-3-carbonsäure (1-(aminocarbonyl) eth-1-yl) amid-derivate und verwandte verbindungen als bradykinin-b1-rezeptorantagonisten zur behandlung von entzündlichen erkrankungen
JP2006526015A (ja) * 2003-05-02 2006-11-16 エラン ファーマシューティカルズ,インコーポレイテッド 炎症疾患治療のためのブラジキニンb1受容体アンタゴニストとしての4−ブロモ−5−(2−クロロ−ベンゾイルアミノ)−1h−ピラゾール−3−カルボン酸アミド誘導体および関連化合物
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
CN104845967B (zh) 2015-04-15 2020-12-11 苏州新海生物科技股份有限公司 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用
WO2018047148A1 (en) 2016-09-12 2018-03-15 Novartis Ag Compounds for the inhibition of mirna
EP3381897A1 (de) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivate des dinatrium 2,2'-{carbonylbis[imino-3,1-phenylencarbonylimino(1-methyl-1h-pyrrol-4,2-diyl)carbonylimino]}dinaphthalen-1,5-disulfonat salzes und verwandte verbindungen als heparanase inhibitoren zur behandlung von krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468642B (sv) * 1985-07-16 1993-02-22 Erba Farmitalia Poly-4-aminopyrrol-2-karboxamidoderivat och foerfarande foer deras framstaellning och en farmaceutisk komposition
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
IT1271456B (it) * 1993-03-01 1997-05-28 Menarini Farma Ind Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizioni farmaceutiche che li contengono
IT1263089B (it) * 1993-04-26 1996-07-24 Menarini Farma Ind Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.

Also Published As

Publication number Publication date
EP0722446B1 (de) 2002-12-11
WO1996005196A1 (en) 1996-02-22
ES2188666T3 (es) 2003-07-01
ZA956590B (en) 1996-03-18
GB9416005D0 (en) 1994-09-28
NO961377D0 (no) 1996-04-03
JPH09504039A (ja) 1997-04-22
CA2172629A1 (en) 1996-02-22
KR960704884A (ko) 1996-10-09
AU3113695A (en) 1996-03-07
NZ290404A (en) 1997-04-24
FI961506A7 (fi) 1996-06-05
US5753629A (en) 1998-05-19
HU9601218D0 (en) 1996-07-29
EP0722446A1 (de) 1996-07-24
PL313821A1 (en) 1996-07-22
DE69529143D1 (en) 2003-01-23
CN1131946A (zh) 1996-09-25
MX9601250A (es) 1998-12-31
DE69529143T2 (de) 2003-09-11
AU689623B2 (en) 1998-04-02
FI961506A0 (fi) 1996-04-03
IL114794A0 (en) 1995-12-08
NO961377L (no) 1996-05-30
HUT76267A (en) 1997-07-28

Similar Documents

Publication Publication Date Title
ATE229524T1 (de) Distamycin a analoga als antitumor- oder antivirale wirkstoffe
NO963439L (no) Sammensetninger inneholdende mikronisert vebivolol
FI970246A0 (fi) Dihydrobentsofuraanit
ATE200669T1 (de) 4-hydroxy-benzopyran-2-one und 4-hydroxy- zykloalkyl(b) - pyran--2-one verwendbarfuer die behandlung von retroviralen infectionen
DE69425273D1 (de) N-substituierte azabicycloalkanderivate als neuroleptika usw.
ATE191334T1 (de) Hydrophilierte zahnabdruckmassen
WO1997030677A3 (en) Pentafluorobenzenesulfonamides and analogs
PL310171A1 (en) Novel imidazopyridines
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
ATE206402T1 (de) 3-acylaminobenzazepine
BR9509970A (pt) Composto
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ATE200482T1 (de) N-substituierte azabicycloheptan-derivate als neuroleptika usw.
ZA9429B (en) Pyrrolidine derivatives their preparation and medicaments containing them
SE9402241L (sv) Inhibitor
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties